Go to main website
Sensus Healthcare - Logo

Press Releases

Sensus Healthcare to Present at the 6th Annual Liolios Gateway Conference on September 6, 2017

BOCA RATON, Fla., Aug. 23, 2017 -- Sensus Healthcare, Inc. (Nasdaq:SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), has been invited to present at the 2017 Gateway Conference, which is being held on September 6-7, 2017 at the Four Seasons Hotel San […]
READ MORE

Sensus Healthcare Reports Record Second Quarter Financial Results

Revenue growth of 39% marks seventh consecutive quarter of double-digit year-over-year gains Conference call begins at 4:30 Eastern time today BOCA RATON, Fla., Aug. 3, 2017 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces financial results […]
READ MORE

Sensus Healthcare Receives Regulatory Approval to Sell the SRT-100™ in China for the Treatment and Prevention of Keloids

BOCA RATON, Fla., July 26, 2017 -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that the SRT-100™ has been cleared by the China Food and Drug Administration (CFDA) to treat and prevent keloids. China accounts for […]
READ MORE

Sensus Healthcare to Host Second Quarter 2017 Financial Results and Business Update Conference Call on August 3, 2017

BOCA RATON, Fla., July 25, 2017 -- Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids, with superficial radiation therapy (SRT), announces that management will hold a conference call beginning at 4:30 p.m. Eastern Time on Thursday, August 3, 2017 to discuss the financial […]
READ MORE

Sensus to Present at the 2017 Marcum MicroCap Conference

BOCA RATON, Fla., June 05, 2017 -- Sensus Healthcare, Inc. (Nasdaq:SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids, with superficial radiation therapy (SRT), today announced Joe Sardano, the Company's Chief Executive Officer, will present a corporate overview to investors at the 2017 Marcum MicroCap Conference on Thursday, […]
READ MORE

Sensus Healthcare Awarded 2017 Technology Leader of the Year for Disruptive Technology from Greater Miami Chamber of Commerce

BOCA RATON, Fla., May 24, 2017 -- Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers (NMSC) and other skin conditions, such as keloids with Superficial Radiotherapy (SRT), has been awarded the 2017 Technology Leader of the Year for the Disruptive Technology category by The Greater Miami […]
READ MORE

Get notified about Sensus Healthcare

Get Email Alerts
Sensus Healthcare - Logo - Footer
Sensus Healthcare partners with The Pinnacle Health Group to provide reimbursement support for all customers. Please contact Pinnacle for support by phone at 866-369-9290 or email at [email protected] Hotline consultants are available Monday through Friday from 8:30 AM to 6:00 PM EST.
Contact Us
Sensus Healthcare World Headquarters:

851 Broken Sound Parkway
Boca Raton, FL 33487
[email protected]

Phone 561.922.5808
Toll-free 800.324.9890
Fax 561.948.2071
© Copyright 2023. Sensus Healthcare - All Rights Reserved.